Results 221 to 230 of about 41,903 (261)
Some of the next articles are maybe not open access.
Pharmacotherapy in Bronchopulmonary Dysplasia
Clinics in Perinatology, 1987This article reviews the current data available on the most frequently used drugs in bronchopulmonary dysplasia. Oxygen, diuretics, bronchodilators, steroids, ribavirin, and antioxidants, as well as medication available for pulmonary hypertension, systemic hypertension, and gastroesophageal reflux are discussed, with emphasis on known advantages, side ...
P W, Blanchard, T M, Brown, A L, Coates
openaire +2 more sources
Biomarkers in Bronchopulmonary Dysplasia
Paediatric Respiratory Reviews, 2013Bronchopulmonary dysplasia (BPD) is a complex disorder secondary to gene-environment interactions, and is the commonest chronic lung disease in infancy. There is no specific or effective treatment available to date for BPD. Since the aetiopathogenesis of BPD is multifactorial, involving diverse molecular signaling pathways, a variety of biomarkers ...
Anita, Bhandari, Vineet, Bhandari
openaire +2 more sources
Observations on bronchopulmonary dysplasia
The Journal of Pediatrics, 1979tension was related to the fetus's relative tolerance for hypoxia and the estimated and known levels of partial pressure of oxygen in the peripheral arterial blood of the fetus prior to delivery. The subsequent use of continuous positive airway pressure, positive end-expiratory pressure, and continuous negative pressure on the chest wall served to ...
openaire +2 more sources
Inflammation and bronchopulmonary dysplasia
Seminars in Neonatology, 2003Pulmonary inflammation is a key feature in the pathogenesis of bronchopulmonary dysplasia (BPD). This inflammatory process, induced by multiple risk factors, is characterized by the presence of inflammatory cells, cytokines and an arsenal of additional humoral mediators in the airways and pulmonary tissue of preterm infants with the condition.
openaire +2 more sources
The Management of Bronchopulmonary Dysplasia
Clinics in Perinatology, 1987After presentation of the actual knowledge concerning the pathophysiology of bronchopulmonary dysplasia, the prevention and the management of the disease are discussed. Techniques of ventilation, weaning procedures and prescription of drugs are also analyzed.
P, Monin, P, Vert
openaire +2 more sources
Prevention of bronchopulmonary dysplasia
Current Opinion in Pediatrics, 2001The clinical syndrome of bronchopulmonary dysplasia (BPD) in preterm infants results primarily from an arrest of lung vascular and alveolar development. The most likely mediators are proinflammatory cytokines that are induced by antenatal exposure to infection, postnatal ventilation, and oxygen exposure.
A H, Jobe, M, Ikegami
openaire +2 more sources
Etiology of Bronchopulmonary Dysplasia
Pediatrics, 1995We read with great interest the article by Groneck et al (Pediatrics. 1994;93:712-718). The authors concluded that an inflammatory reaction is present in the lungs of preterm infants prone to develop bronchopulmonary dysplasia (BPD), and they suggested that this concept of inflammation could link the pathophysiological gap between barotrauma- and ...
PAPOFF, PAOLA, PACIFICO, Lucia, Bucci G.
openaire +2 more sources
Bronchopulmonary dysplasia: a review
Archives of Gynecology and Obstetrics, 2013The prevalence of bronchopulmonary dysplasia (BPD), one of the most frequently occurring complications following preterm birth, is increasing due to increased survival of preterm infants.Systematic literature review.The etiology is multifactorial, with prematurity being a prerequisite for the development of BPD.
Zarqa, Ali +3 more
openaire +2 more sources
Nutrition and bronchopulmonary dysplasia
The Journal of Maternal-Fetal & Neonatal Medicine, 2012We aimed to assess the current knowledge on the nutritional management of preterm infants at risk of developing bronchopulmonary dysplasia (BPD) or with BPD. We considered the evidence supporting the actual fluid and energy intake, proteins, lipids, and electrolytes requirement, and need for other nutrients in preterm infant at risk of developing BPD ...
DANI, CARLO, C. Poggi
openaire +3 more sources
Hypocarbia and Bronchopulmonary Dysplasia
Archives of Pediatrics & Adolescent Medicine, 1995GARLAND ET al 1 report in this issue that a retrospective observational analysis of multiple possible risk variables for bronchopulmonary dysplasia (BPD) turned up the association of low Pco 2 values before surfactant treatment with BPD. Intuitively, low Pco 2 values suggest better lung function in the preterm infant and might be expected to indicate a
openaire +2 more sources